RIOCIGUAT vs RISANKIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RIOCIGUAT vs RISANKIZUMAB: Safety Overview
| Metric | RIOCIGUAT | RISANKIZUMAB |
|---|---|---|
| Total FAERS Reports | 18,268 | 2,642 |
| Deaths Reported | 5,380 | 41 |
| Death Rate | 29.5% | 1.6% |
| Hospitalizations | 7,951 | 439 |
| Average Patient Age | 63.9 yrs | 52.1 yrs |
| % Female Patients | 70.6% | 51.3% |
| FDA Approval Date | Oct 8, 2013 | N/A |
| Manufacturer | Bayer HealthCare Pharmaceuticals Inc. | AbbVie Inc. |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | N/A |